Global trends and research hotspots in perioperative management of lung cancer: a bibliometric analysis from 2004 to 2024

被引:2
作者
Jiang, Qinling [1 ]
Wei, Zhuheng [2 ]
Liu, Pingping [3 ]
Li, Zonghuai [2 ]
Jiang, Huiqin [1 ]
Cao, Yilin [1 ]
Zhang, Bo [2 ]
Yan, Yuanyuan [3 ]
He, Yulong [1 ]
机构
[1] Nanxishan Hosp Guangxi Zhuang Autonomous Reg, Dept Oncol, Guilin, Peoples R China
[2] Guilin Med Univ, Sci Res Ctr, Guilin, Peoples R China
[3] Sanya Cent Hosp, Peoples Hosp Hainan Prov 3, Dept Pharm, Sanya, Hainan, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
lung cancer; perioperative management; immunotherapy; targeted drugs; bibliometric; TO-LYMPHOCYTE RATIO; LONG-TERM IMPACT; POSTOPERATIVE COMPLICATIONS; RECURRENCE; SURGERY; IMMUNOTHERAPY; PREDICTOR; THERAPY; CTLA-4; EGFR;
D O I
10.3389/fimmu.2024.1500686
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective This article aims to analyze the current status and research hotspots of literature related to perioperative management of patients with Lung Cancer and provide reference for future research directions.Methods This study conducted a bibliometric analysis of research literature related to perioperative management of Lung Cancer published between 2004 and 2024, retrieved from the Web of Science database. R software and VOSviewer were used for analyzing keyword clusters and research themes, revealing trends and frontiers in this field.Results A total of 4,942 studies on perioperative management of lung cancer were included. In recent years, research in this area has shown a global upward trend, with particular focus on surgical risk assessment, complication prevention, and postoperative management. Perioperative biomarkers before and after surgery have emerged as a central focus due to their impact on diagnosis and treatment. The application of novel therapies, such as targeted drugs and immunotherapy, in perioperative management is also becoming a significant research hotspot. Additionally, China has been a leading contributor to research output in this field, demonstrating strong performance in international collaborations.Conclusion Perioperative management is a critical factor influencing the prognosis of Resectable lung cancer patients. Through a systematic analysis of the current status and research hotspots in perioperative management of lung cancer, this study provides valuable references for future clinical practice and research, particularly regarding the integration of novel therapies to optimize patient outcomes.
引用
收藏
页数:15
相关论文
共 89 条
[1]   Circulating Tumor Cells: Liquid Biopsy of Cancer [J].
Alix-Panabieres, Catherine ;
Pantel, Klaus .
CLINICAL CHEMISTRY, 2013, 59 (01) :110-118
[2]   bibliometrix: An R-tool for comprehensive science mapping analysis [J].
Aria, Massimo ;
Cuccurullo, Corrado .
JOURNAL OF INFORMETRICS, 2017, 11 (04) :959-975
[3]  
Bai F., 2023, Bibliometric and visual analysis in the field of traditional Chinese medicine in cancer from 2002 to 2022, P14, DOI [10.3389/fphar.2023.1164425, DOI 10.3389/FPHAR.2023.1164425]
[4]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[5]   Risk Factors for Morbidity After Lobectomy for Lung Cancer in Elderly Patients [J].
Berry, Mark F. ;
Hanna, Jennifer ;
Tong, Betty C. ;
Burfeind, William R., Jr. ;
Harpole, David H. ;
D'Amico, Thomas A. ;
Onaitis, Mark W. .
ANNALS OF THORACIC SURGERY, 2009, 88 (04) :1093-1099
[6]   Recent advances in lung cancer research: unravelling the future of treatment [J].
Bertolaccini, Luca ;
Casiraghi, Monica ;
Uslenghi, Clarissa ;
Maiorca, Sebastiano ;
Spaggiari, Lorenzo .
UPDATES IN SURGERY, 2024, 76 (06) :2129-2140
[7]   Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies [J].
Bettegowda, Chetan ;
Sausen, Mark ;
Leary, Rebecca J. ;
Kinde, Isaac ;
Wang, Yuxuan ;
Agrawal, Nishant ;
Bartlett, Bjarne R. ;
Wang, Hao ;
Luber, Brandon ;
Alani, Rhoda M. ;
Antonarakis, Emmanuel S. ;
Azad, Nilofer S. ;
Bardelli, Alberto ;
Brem, Henry ;
Cameron, John L. ;
Lee, Clarence C. ;
Fecher, Leslie A. ;
Gallia, Gary L. ;
Gibbs, Peter ;
Le, Dung ;
Giuntoli, Robert L. ;
Goggins, Michael ;
Hogarty, Michael D. ;
Holdhoff, Matthias ;
Hong, Seung-Mo ;
Jiao, Yuchen ;
Juhl, Hartmut H. ;
Kim, Jenny J. ;
Siravegna, Giulia ;
Laheru, Daniel A. ;
Lauricella, Calogero ;
Lim, Michael ;
Lipson, Evan J. ;
Marie, Suely Kazue Nagahashi ;
Netto, George J. ;
Oliner, Kelly S. ;
Olivi, Alessandro ;
Olsson, Louise ;
Riggins, Gregory J. ;
Sartore-Bianchi, Andrea ;
Schmidt, Kerstin ;
Shih, Ie-Ming ;
Oba-Shinjo, Sueli Mieko ;
Siena, Salvatore ;
Theodorescu, Dan ;
Tie, Jeanne ;
Harkins, Timothy T. ;
Veronese, Silvio ;
Wang, Tian-Li ;
Weingart, Jon D. .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)
[8]   Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study [J].
Blakely, Collin M. ;
Urisman, Anatoly ;
Gubens, Matthew A. ;
Mulvey, Claire K. ;
Allen, Greg M. ;
Shiboski, Stephen C. ;
Rotow, Julia K. ;
Chakrabarti, Turja ;
Kerr, D. Lucas ;
Aredo, Jacqueline V. ;
Bacaltos, Bianca ;
Gee, Megan ;
Tan, Lisa ;
Jones, Kirk D. ;
Devine, W. Patrick ;
Doebele, Robert C. ;
Aisner, Dara L. ;
Patil, Tejas ;
Schenk, Erin L. ;
Bivona, Trever G. ;
Riess, Jonathan W. ;
Coleman, Melissa ;
Kratz, Johannes R. ;
Jablons, David M. .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (26) :3105-3114
[9]   Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Bray, Freddie ;
Laversanne, Mathieu ;
Sung, Hyuna ;
Ferlay, Jacques ;
Siegel, Rebecca L. ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (03) :229-263
[10]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]